Clinical Trials Logo

Pain, Postoperative clinical trials

View clinical trials related to Pain, Postoperative.

Filter by:

NCT ID: NCT05459220 Not yet recruiting - Clinical trials for Postoperative Pain Of Laparoscopic Surgery

A Trial of SHR0410 Injection for the Treatment of Pain After Laparoscopic Surgery

Start date: July 2022
Phase: Phase 3
Study type: Interventional

The study is being conducted to evaluate the efficacy and safety of SHR0410 injection for the treatment of pain after laparoscopic surgery

NCT ID: NCT05450055 Not yet recruiting - Ovarian Cancer Clinical Trials

Intraperitoneal Lidocaine in Ovarian Cancer Surgery

Start date: July 18, 2022
Phase: N/A
Study type: Interventional

The main objective of this trial is to improve the postoperative analgesia effect and prognosis of patients with ovarian cancer after laparotomy surgery. This is a randomized, double-blind, controlled trial to evaluate analgesia and patient outcomes after local peritoneal anesthesia after surgery.

NCT ID: NCT05446636 Not yet recruiting - Circadian Rhythm Clinical Trials

Circadian Rhythm Status and CS (Cesarean Section) Postoperative Pain

Start date: August 14, 2022
Phase:
Study type: Observational

Use huawei wristwatch to record maternal rhythm status and record the VAS score after cesarean section under combined spinal-epidural anesthesia. Based on this study the investigators intend to explore the correlation between maternal circadian rhythm status and postoperative pain after cesarean section.

NCT ID: NCT05446311 Not yet recruiting - Analgesia Clinical Trials

Naldebain® Extended-release Injection After Cesarean Section in Pain Management

Start date: July 15, 2022
Phase:
Study type: Observational

Cesarean section is one of the surgeries most commonly leading to postoperative severe acute pain. It was reported that the mean worst pain intensity reached to 6.14 one day after cesarean section in Germany. Inadequate pain management may result in the cardiorespiratory complications, late recovery, and postoperative chronic pain. According to a series of pain management article published in the Lancent in 2019, the incidence of post-cesarean section chronic pain was 55%, including 12% of severe chronic pain. Extended-release dinalbuphine sebacate, a prodrug of nalbuphine, is a novel analgesic developed in Taiwan and the indication is moderate to severe postoperative pain. After intramuscular injected, dinalbuphine sebacate will be released to blood stream and immediately hydrolyzed. In Taiwan, dinalbuphine sebacate has been used for alleviating pain after several types of surgeries, such as colorectal surgery, orthopaedics, gynecology and obstetrics. However, few post-marketing studies investigated the efficacy and safety of dinalbuphine sebacate.

NCT ID: NCT05439707 Not yet recruiting - Clinical trials for Postoperative Delirium

Effects of Perioperative Transauricular Vagus Nerve Electrical Stimulation on POD, POCD and CPSP

Start date: October 1, 2022
Phase: N/A
Study type: Interventional

Postoperative delirium (POD) and postoperative cognitive dysfunction (POCD) occur in 11-51% of patients after surgery, and its prevalence increases with age. The occurrence of delirium is associated with increased morbidity and mortality, prolonged hospital stay, worse functional recovery. Orthopedic procedures and specifically joint replacements have been considered as a major risk for development of chronic postsurgical pain (CPSP). Approximately 13-44% of patients will develop CPSP after knee or hip arthOpioid abuseroplasty. CPSP may cause the discomfort, distress, disability and opioid abuse. Mounting evidence has revealed that inflammation triggered by surgical trauma plays a key role in POD, POCD and CPSP. Recent studies found that vagus nerve stimulation showed the suppression of inflammation. In this study, the effect of perioperative transauricular vagus nerve stimulation on the prognosis of patients undergoing arthroplasty will be investigated, providing potential solutions for the prevention and treatment of postoperative cognitive dysfunction, postoperative delirium and chronic postsurgical pain.

NCT ID: NCT05409742 Not yet recruiting - Clinical trials for Masseter Muscle Activity

Masseter Muscle Activity and Post-operative Pain in a Group of Egyptian Children Treated With Hall Technique Vs Modified Hall Technique

Start date: October 1, 2022
Phase: N/A
Study type: Interventional

The study aims to evaluate postoperative pain and masseter muscle activity in a group of Egyptian children with carious primary molars treated with Hall Vs modified Hall Technique (with proximal and occlusal reduction).

NCT ID: NCT05400382 Not yet recruiting - Pain, Postoperative Clinical Trials

Mindfulness to Reduce Post-cesarean Pain and Prevent Postpartum Depression

MaMiDaPP
Start date: July 1, 2023
Phase: N/A
Study type: Interventional

This study will test the effect of a mobile mindfulness-based intervention on reducing post-cesarean delivery pain and preventing postpartum depression.

NCT ID: NCT05393908 Not yet recruiting - Post-operative Pain Clinical Trials

Intraoperative TAP Block After Repeat Cesarean

Start date: January 1, 2025
Phase: N/A
Study type: Interventional

The aim of this study is to perform a randomized trial to investigate if intraoperative surgeon administered TAP block reduces pain and use of oral and parenteral pain medications after repeat cesarean delivery. The investigators aim to compare surgeon administered TAP block with liposomal bupivacaine compared to standard treatment (i.e. no TAP block) with regard to the primary outcome of post-operative narcotic use.

NCT ID: NCT05386121 Not yet recruiting - Clinical trials for Postoperative Pain, Acute

Erector Spinae Plane Block Versus Quadratus Lumborum Block for Open Renal Surgeries in Children

Start date: May 20, 2022
Phase: Phase 4
Study type: Interventional

Open renal surgeries are associated with significant postoperative pain; early control of the perioperative pain is associated with decrease of hemodynamic variations during the surgery, early mobilization, better quality of functional recovery & early discharge of patients. Side effects of systemic opioids, as well as difficulty to monitor their response, are major limitations to their use. Pediatric regional anesthesia (PRA) is one of the most valuable and safe tools to treat perioperative pain, and is an essential part of modern anesthetic practice. Neuraxial analgesia for pediatric patients is a mode of pain control that gained popularity in the last few decades as it decreases opioid exposure, shortens recovery room time & hospital stay. Caudal block is the most commonly used neuraxial anesthesia in pediatric patients. However, its major side effect is urinary retention and excessive motor block. Considerable progress has been made in the practice of PRA over the past few years including incorporation of ultrasound guidance, with promising novel regional anesthesia techniques, especially the anterolateral and the posterolateral trunk blocks. In this study, the investigators will compare the ultrasound guided quadratus lumborum block (QLB) with erector spinae plane block (ESPB), regarding the duration and quality of postoperative analgesia in pediatric patients undergoing unilateral open renal surgeries under general anesthesia. The study hypothesis is that QLB can provide a more superior postoperative pain relief to ESPB in children undergoing open renal surgeries.

NCT ID: NCT05385523 Not yet recruiting - Clinical trials for Postoperative Pain, Acute

Dexamedatomidine vs. Dexamethasone in Rhomboidal Intercostal Plain Block and Subserratus Block in Breast Surgery

Start date: May 20, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the analgesic efficacy and safety of adding dexmedetomidine and dexamethasone to bupivacaine in rhomboidal intercostal and subserratus (RISS) block for patients undergoing modified radical mastectomy compared to bupivacaine only.